Bromocriptine for Idiopathic Intracranial Hypertension: A Retrospective Multicenter Cohort Study.

Int J Gen Med · 2025 · PMC11977546 · PMID 40201930

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

By 24 months, the bromocriptine group showed a trend toward lower incidence of papilledema compared to controls (12/136 patients [8.82%] vs 22/136 patients [16.18%], risk difference: 7.30%, RR: 0.50, 95% CI: 0.243–1.028, p=0.053), approaching but not reaching statistical significance.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.